Translate Bio Prioritizes Development of CF Therapy MRT5005, Other Lung Disease Candidates
News
Translate Bio is going to focus on the development of potential therapies to treat pulmonary diseases, including its lead candidate, MRT5005, targeting the underlying cause of cystic fibrosis (CF), the company announced. MRT5005 ... Read more